Literature DB >> 29564815

Clinical Consequences of Chromothripsis and Other Catastrophic Cellular Events.

Maki Fukami1, Hiroki Kurahashi2.   

Abstract

Chromothripsis was initially described as a novel cause of chromosomal rearrangements in cancer cells and was subsequently implicated in the development of gross chromosomal rearrangements in the germline. Other catastrophic cellular events such as chromoanasynthesis and chromoplexy have also been observed in human cells. Such events have been associated with various phenotypes including mental retardation and congenital malformations. Here, we introduce representative cases of human disorders arising from somatic or germline chromothripsis or similar catastrophic events. In this chapter, we use the term "chromoanagenesis" to indicate all catastrophic events including chromothripsis.

Entities:  

Keywords:  Congenital anomaly; Deletion; Duplication; Gene; Germline; Rearrangement; Tumor

Mesh:

Year:  2018        PMID: 29564815     DOI: 10.1007/978-1-4939-7780-2_2

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  4 in total

1.  Stable transmission of complex chromosomal rearrangements involving chromosome 1q derived from constitutional chromoanagenesis.

Authors:  Mary A Gudipati; Elizabeth Waters; Carol Greene; Nidhi Goel; Nicole L Hoppman; Beth A Pitel; Matthew R Webley; Ying Zou
Journal:  Mol Cytogenet       Date:  2019-10-31       Impact factor: 2.009

Review 2.  Cytokinesis-Block Micronucleus Cytome Assay Evolution into a More Comprehensive Method to Measure Chromosomal Instability.

Authors:  Michael Fenech
Journal:  Genes (Basel)       Date:  2020-10-15       Impact factor: 4.096

Review 3.  Chromoanagenesis: cataclysms behind complex chromosomal rearrangements.

Authors:  Franck Pellestor
Journal:  Mol Cytogenet       Date:  2019-02-11       Impact factor: 2.009

Review 4.  Insight into the Molecular Basis Underlying Chromothripsis.

Authors:  Katarzyna Ostapińska; Borys Styka; Monika Lejman
Journal:  Int J Mol Sci       Date:  2022-03-19       Impact factor: 5.923

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.